手术防沾黏屏障市场:管道报告(发展阶段、细分市场、地区/国家、监管途径、主要参与者),2023 年最新版
市场调查报告书
商品编码
1405127

手术防沾黏屏障市场:管道报告(发展阶段、细分市场、地区/国家、监管途径、主要参与者),2023 年最新版

Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update

出版日期: | 出版商: GlobalData | 英文 66 Pages | 订单完成后即时交付

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

沾黏是疤痕样组织带,形成异常纤维连接,在异常位置连接组织表面。一般来说,任何类型的经腹膜手术都可能导致沾黏的形成,从浆膜表面的最小疤痕到几乎任何结构的牢固聚集。

本报告调查了手术沾黏屏障市场,并提供了产品概述、正在开发的管道产品趋势、不同开发阶段产品的比较分析、正在进行的临床试验资讯以及参与公司的最新趋势等。

目录

第一章 内容

第 2 章 简介

第三章 开发中产品

  • 手术防沾黏屏障 - 按开发阶段划分的管道产品
  • 外科防沾黏屏障 - 按细分市场划分的管道产品
  • 手术防沾黏屏障 - 区域管道产品
  • 外科防沾黏屏障 - 按监管途径分类的管道产品
  • 外科防沾黏屏障 - 管道产品(按预计批准日期)
  • 手术防沾黏屏障 - 正在进行的临床试验

第4章:手术防沾黏屏障-公司正在开发的管道产品

  • 手术沾黏屏障公司 - 按开发阶段划分的管道产品
  • 手术防沾黏屏障 - 按开发阶段划分的管道产品

第五章 手术防沾黏屏障公司及产品概述

第六章 手术沾黏预防屏障 - 最新进展

第7章附录

Abstract

GlobalData's Medical Devices sector report, "Surgical Adhesion Barriers Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update" provides comprehensive information about the Surgical Adhesion Barriers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Adhesions are bands of scar-like tissue that forms abnormal fibrous connections joining tissue surfaces in abnormal locations. In general, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of serosal surface to firm agglutination of nearly all structures.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Surgical Adhesion Barriers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Surgical Adhesion Barriers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Surgical Adhesion Barriers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Surgical Adhesion Barriers Overview

3 Products under Development

  • 3.1 Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • 3.2 Surgical Adhesion Barriers - Pipeline Products by Segment
  • 3.3 Surgical Adhesion Barriers - Pipeline Products by Territory
  • 3.4 Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
  • 3.5 Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
  • 3.6 Surgical Adhesion Barriers - Ongoing Clinical Trials

4 Surgical Adhesion Barriers - Pipeline Products under Development by Companies

  • 4.1 Surgical Adhesion Barriers Companies - Pipeline Products by Stage of Development
  • 4.2 Surgical Adhesion Barriers - Pipeline Products by Stage of Development

5 Surgical Adhesion Barriers Companies and Product Overview

6 Surgical Adhesion Barriers- Recent Developments

  • 6.1 Jul 21, 2023: Seikagaku Announces Favorable Results From A Pivotal Study for Si-449, an Adhesion Barrier
  • 6.2 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO
  • 6.3 May 17, 2023: S2Medical AB (publ) signs a distribution agreement for the Iranian market
  • 6.4 Apr 13, 2023: S2Medical AB (publ) signs a distributor agreement in the United Arab Emirates and delivers a record order of the skin substitute Epiprotect worth about SEK 2 million

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • Surgical Adhesion Barriers - Pipeline Products by Segment
  • Surgical Adhesion Barriers - Pipeline Products by Territory
  • Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
  • Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
  • Surgical Adhesion Barriers - Ongoing Clinical Trials
  • Surgical Adhesion Barriers Companies - Pipeline Products by Stage of Development
  • Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Surgical Adhesion Barriers - Pipeline Products by Stage of Development
  • Surgical Adhesion Barriers - Pipeline Products by Segment
  • Surgical Adhesion Barriers - Pipeline Products by Territory
  • Surgical Adhesion Barriers - Pipeline Products by Regulatory Path
  • Surgical Adhesion Barriers - Pipeline Products by Estimated Approval Date
  • Surgical Adhesion Barriers - Ongoing Clinical Trials